MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis

PURPOSE: Patients with poorly controlled allergic rhinitis (AR) experience nasal symptoms, sleep disturbances, activity impairment, and decreased quality-of-life (QoL). MP-AzeFlu is safe and effective for moderate-to-severe seasonal and perennial AR, but its impact on QoL requires investigation in t...

Descripción completa

Detalles Bibliográficos
Autores principales: van Weissenbruch, Ranny, Klimek, Ludger, Gálffy, Gabriella, Emmeluth, Melanie, Koltun, Arkady, Kopietz, Ferdinand, Nguyen, Duc Tung, Kuhl, Hans Christian, Pohl, Wolfgang, Scadding, Glenis K, Price, David, Mullol, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719305/
https://www.ncbi.nlm.nih.gov/pubmed/33293835
http://dx.doi.org/10.2147/JAA.S277734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719305/
https://www.ncbi.nlm.nih.gov/pubmed/33293835
http://dx.doi.org/10.2147/JAA.S277734

Ejemplares similares